Northern Trust’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.01M | Buy |
841,037
+118,575
| +16% | +$1.13M | ﹤0.01% | 2199 |
|
|
2025
Q1 | $7.56M | Sell |
722,462
-54,551
| -7% | -$571K | ﹤0.01% | 2203 |
|
|
2024
Q4 | $18.3M | Buy |
777,013
+55,511
| +8% | +$1.31M | ﹤0.01% | 1751 |
|
|
2024
Q3 | $25.9M | Buy |
721,502
+101,863
| +16% | +$3.66M | ﹤0.01% | 1465 |
|
|
2024
Q2 | $21.9M | Buy |
619,639
+72,604
| +13% | +$2.56M | ﹤0.01% | 1497 |
|
|
2024
Q1 | $15.5M | Buy |
547,035
+123,950
| +29% | +$3.52M | ﹤0.01% | 1768 |
|
|
2023
Q4 | $5.63M | Buy |
423,085
+28,834
| +7% | +$383K | ﹤0.01% | 2428 |
|
|
2023
Q3 | $3.53M | Buy |
394,251
+13,323
| +3% | +$119K | ﹤0.01% | 2642 |
|
|
2023
Q2 | $4.29M | Buy |
380,928
+106,455
| +39% | +$1.2M | ﹤0.01% | 2585 |
|
|
2023
Q1 | $3.16M | Sell |
274,473
-6,562
| -2% | -$75.6K | ﹤0.01% | 2725 |
|
|
2022
Q4 | $3.26M | Buy |
281,035
+14,454
| +5% | +$168K | ﹤0.01% | 2735 |
|
|
2022
Q3 | $3.39M | Buy |
266,581
+543
| +0.2% | +$6.9K | ﹤0.01% | 2720 |
|
|
2022
Q2 | $1.83M | Buy |
266,038
+9,374
| +4% | +$64.4K | ﹤0.01% | 3113 |
|
|
2022
Q1 | $2.47M | Sell |
256,664
-4,571
| -2% | -$44.1K | ﹤0.01% | 2990 |
|
|
2021
Q4 | $3.11M | Buy |
261,235
+4,023
| +2% | +$47.8K | ﹤0.01% | 2987 |
|
|
2021
Q3 | $4.18M | Sell |
257,212
-13,019
| -5% | -$211K | ﹤0.01% | 2844 |
|
|
2021
Q2 | $5.69M | Buy |
270,231
+94,786
| +54% | +$1.99M | ﹤0.01% | 2768 |
|
|
2021
Q1 | $2.72M | Buy |
175,445
+13,135
| +8% | +$204K | ﹤0.01% | 3086 |
|
|
2020
Q4 | $3.41M | Buy |
+162,310
| New | +$3.41M | ﹤0.01% | 2897 |
|